英语释义

• an abnormal lowering of the white blood cell count

片语

leucopenia a白细胞减少

Animal model of leucopenia白细胞减少癥动物模型

reversible leucopenia可复原白血球减少病

chemotherapy-induced leucopenia化疗所致白细胞减少癥

WBC Leucopenia白血球减少癥

leucopenia leukopenia白血球减少癥

drugs for leucopenia升白细胞药

grade iv leucopeniaiv度白细胞减少

leucopenia after chemotherapy化疗后白细胞减少癥

leukocytopenia[内科] 白细胞减少

英汉例句

• objective to study the leukogenic effects on leucopenia model induced by x-ray and chemotherapy.

  方法通过制备小鼠和家兔白细胞减少实验动物模型，观察香菇多糖的升白作用。

• it is used tablet and injection etc, and curing cancer, leucopenia disease, chronic tracheitis of bronchus asthma and panting mould, bacillary dysentery and enteritis etc.

  用于片剂、针剂等。治疗癌癥、白细胞减少癥、支气管哮喘和喘息型慢性气管炎、细菌性痢疾及肠炎等。

• most common adverse events were leucopenia (60%), anemia (62%), nausea and vomiting (30%), alopecia (100%). there were no chemotherapy-related deaths.

  主要不良反应是白细胞下降（60％）、贫血（62％）、恶心呕吐（30％）、脱发（100％），未出现与化疗相关的死亡。

• methods:using pharmacoeconomic cost-effectiveness analysis, gm-csf was compared with g-csf in treatment of leucopenia in chemotherapy of cancer.

  方法：运用药物经济学成本—效果分析方法，对灵桿菌素和惠尔血治疗化疗病人白细胞下降的疗效及成本进行评价。

• result the incidence rate of leucopenia in treatment group(25%) was lower than that in control group(70%, p0.01) after treatment.

  结果治疗组用药后白细胞减少的发生率为25%，对照组为70%，2组比较有显着性差异（p0.01）。

• because of the occurrence of leucopenia and/or diarrhoea, cellcept has been dramatically decreased in 33% of cases and required the re-introduction of steroids.

  由于发生腹泻和白细胞减少癥，33％的患者骁悉明显减量，且需要重新使用激素。

• conclusion the changing regularity of the hypocellular leucopenia after chemotherapy could be significant reference for clinical treatment.

  结论化疗后白细胞减少的变化规律对临床治疗有参考意义。

• aim:to compare the therapeutic effect, adverse reactions and the costs between gm-csf and g-csf in treating leucopenia in chemotherapy of cancer.

  目的：观察灵桿菌素、惠尔血治疗化疗病人白细胞下降的疗效、不良反应及成本—效果对比。

• objective to investigate the treatment of grade iv leucopenia after chemotherapy in patients with carcinoma.

  目的研究肿瘤患者化疗后iv度白细胞减少的综合救治方法。

• myelosuppression such as leucopenia in prevention group and control group were 17.6% and 22.1 %, respectively(p> 0.05).

  预防组白细胞减少发生率为17.6%，对照组为22.1%，差异无统计学意义（p〉0.05）。

• the patient developed diarrhea, fever and leucopenia during anti-rheumatoid drug treatments.

  患者在抗风湿药物治疗中出现腹泻、发热及粒细胞缺乏等表现。